Adam Shlien

Biochemistry, Genetics and Molecular Biology · Life Sciences

49h-index21.7kcitations477works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(96), Sarcoma Diagnosis and Treatment(75), Glioma Diagnosis and Treatment(74), Neuroblastoma Research and Treatments(72), Cancer-related Molecular Pathways(69)

Publications475 total

Supplemental Table 1 from Advancing Preclinical Biology for Ewing Sarcoma: An International Effort
2026Open Access
Data from Advancing Preclinical Biology for Ewing Sarcoma: An International Effort
2026Open Access
Patterns of hypermutation shape tumorigenesis and immunotherapy response in mismatch-repair-deficient glioma
Nature Genetics·2025
Comprehensive and rapid detection of genomic alterations in pediatric leukemias using whole-genome sequencing with adaptive sampling
Blood·2025
Extensive and differential platinum chemotherapy mutagenesis in children
2025Open Access
Single-workflow Nanopore whole genome sequencing with adaptive sampling for accelerated and comprehensive pediatric cancer profiling
2025Open Access
Abstract B006: Tissue-specific mutational outcomes underlying the late effects of anthracyclines on tumours, blood, and heart
Cancer Research·2025
Abstract A016: ews-nf: A custom workflow for tumor cell annotation and analysis of single-cell RNA-sequencing of paired patient Ewing sarcoma specimens from the Sean Karl cohort
Cancer Research·2025
Abstract B039: Exploring the early genetic determinants of tumor risk in Li-Fraumeni Syndrome
Cancer Research·2025
Abstract A015: Targetable gene dependencies in Ewing sarcoma subtypes
Cancer Research·2025
Abstract B002: Rapid and accurate diagnosis of childhood cancers using long-read nanopore RNA sequencing
Cancer Research·2025
Supplementary Table 3 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
2025Open Access
Supplementary Table 5 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
2025Open Access
Supplementary Figure 2 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
2025Open Access
Data from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
2025Open Access
Supplementary Figure 1 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
2025Open Access
Supplementary Table 1 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
2025Open Access
Supplementary Figure 3 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
2025Open Access
Supplementary Table 2 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
2025Open Access
Supplementary Table 4 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
2025Open Access
page 1 of 24Next →

Frequent Co-authors

David Malkin(20), Uri Tabori(16), Michael R. Stratton(14), Adam P. Butler(13), Peter J. Campbell(13), Ludmil B. Alexandrov(12), Patrick Tarpey(12), Jon W. Teague(12), P. Andrew Futreal(11), Cynthia Hawkins(11), David C. Wedge(10), Peter Van Loo(10), Helen Davies(10), Serena Nik‐Zainal(9), Keiran Raine(9), Sancha Martin(9), Elli Papaemmanuil(9), Éric Bouffet(9), Sam Behjati(9), Adrienne M. Flanagan(8)